DUAL ANTIPLATELET THERAPY
Clinical trials for DUAL ANTIPLATELET THERAPY explained in plain language.
Never miss a new study
Get alerted when new DUAL ANTIPLATELET THERAPY trials appear
Sign up with your email to follow new studies for DUAL ANTIPLATELET THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a shorter course of blood thinners be safer after a heart attack?
Disease control Recruiting nowThis study looks at people who have had a severe type of heart attack called STEMI. It compares a shorter course (about one month) of two blood thinners followed by just one drug (prasugrel) for a year, versus the standard one-year regimen of two blood thinners. The goal is to se…
Matched conditions: DUAL ANTIPLATELET THERAPY
Phase: PHASE4 • Sponsor: Research Maatschap Cardiologen Rotterdam Zuid • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could one blood thinner be safer than two for older heart patients?
Disease control Recruiting nowThis study looks at whether taking just one blood thinner (single antiplatelet therapy) is safer and as effective as taking two (dual antiplatelet therapy) in older adults or those at high risk of bleeding who have had a balloon procedure to open blocked heart arteries. About 576…
Matched conditions: DUAL ANTIPLATELET THERAPY
Phase: NA • Sponsor: Fondazione Ricerca e Innovazione Cardiovascolare ETS • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC